Lexicon Pharmaceuticals, Inc. ( LXRX) - Key Metrics
LXRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.02 | -$0.04 | -$0.05 | -$0.05 |
| 2025Q3 | $0.04 | -$0.04 | -$0.07 | -$0.07 |
| 2025Q2 | $0.08 | $0.01 | $0.05 | $0.05 |
| 2025Q1 | $0 | -$0.07 | -$0.12 | -$0.12 |
LXRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.73 |
| 2025Q3 | ? | -9.61 |
| 2025Q2 | ? | 26.41 |
| 2025Q1 | ? | -1.65 |
LXRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.36% | ? |
| 2025Q4 | -4.12% | ? |
| 2025Q3 | -4.86% | ? |
| 2025Q2 | 4.95% | ? |
| 2025Q1 | -26.24% | ? |
LXRX
Price: $1.94
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 131023
Ebitda: -28.2 millionMarket Capitalization: 806.1 million